Navicare Biotech Co., Ltd.(TW:8472)
NT$48.15-1.80 (-1.73%)
TW:8472
Navicare Biotech Co., Ltd. Revenue
NT$48.15
At close:-1.80 (-1.73%)
Navicare Biotech Co., Ltd. (8472) Revenue
Navicare Biotech Co., Ltd. Revenue
Navicare Biotech Co., Ltd. had a revenue of 125.91M in the quarter ending Jun 30, 2026, with 2.51%. This bring the company's revenue in the last twelve months to 505.82M, Decreased 1.85%. In the fiscal year ending Dec 31, 2025, Navicare Biotech Co., Ltd. had annual revenue of 478.07M with 41.85% growth.
- Revenue (ttm)
- 505.82M
- Revenue Growth
- 19.68%
- P/S Ratio
- 1.79
- Revenue/Employee
- TWD 5,975,900
- Employees
- 80
- Market Cap
- TWD 853.98M
Revenue Chart
Navicare Biotech Co., Ltd. Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 478.07M | 141.04M | 41.85% |
| Dec 31, 2024 | 337.03M | -51.47M | -13.25% |
| Dec 31, 2023 | 388.50M | 56.95M | 17.18% |
| Mar 31, 2023 | 331.55M | 26.27M | 8.60% |
| Dec 31, 2021 | 305.28M | -109.14M | -26.33% |
| Dec 31, 2020 | 414.42M | -30.33M | -6.82% |
| Dec 31, 2019 | 444.75M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.